NDUFAF2 and diffuse large B-cell lymphoma: The expression level of NDUFAF2 was markedly greater in tumor tissues, such as adrenocortical carcinoma (ACC), cholangiocarcinoma (CHOL), diffuse large B cell lymphoma (DLBCL), glioblastoma multiforme (GBM), kidney renal papillary cell carcinoma (KIRP), kidney renal clear cell carcinoma (KIRC), low-grade glioma (LGG), LUAD, liver hepatocellular carcinoma (LIHC), prostate adenocarcinoma (PRAD), pancreas adenocarcinoma (PAAD), skin cutaneous melanoma (SKCM), rectal adenocarcinoma (READ), thymoma (THYM), stomach adenocarcinoma (STAD), and thyroid carcinoma (THCA).